Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A

Lili Yuan(Taizhou People's Hospital), Chunyu Cao(Nantong University)
Clinical Cosmetic and Investigational Dermatology
September 1, 2023
Cited by 18


Related Papers